Evidence map›Paper›PMID 41445540›Full record

SynthesisInternational journal of nanomedicine2025

New Strategies in Comprehensive Melanoma Treatment: Applications, Potential, and Challenges of Hydrogels.

Qiang Jin, Shi-Qi Lin, Xiang-Jie Xue, Li-Li Wang, Miao-Yun Jiang, Ji Wang, Su-Fan Wu, Yan-Yan Hu

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiang JinCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Shi-Qi LinCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Xiang-Jie XueCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Li-Li WangCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Miao-Yun JiangCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Ji WangCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Su-Fan WuCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Yan-Yan HuCenter for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rising incidence and mortality rates of melanoma, the limitations of traditional treatment methods have become increasingly evident. These approaches often lack precision, cause systemic toxicity, or fail to prevent recurrence, falling short of current treatment needs such as efficacy, safety, and long-term tumor control. Melanoma progression involves complex biological features such as uncontrolled proliferation, immune evasion, and metastasis, which are crucial for understanding clinical behavior and guiding treatment design. Hydrogels have recently emerged as a promising platform in the field of cancer therapy due to their tunable physicochemical properties, biocompatibility, and capacity for localized, controlled drug delivery. To provide a comprehensive and methodologically sound overview, we systematically searched the PubMed database using the keywords "hydrogel" and "melanoma" for studies published up to December 2024. Studies were screened based on relevance, originality, and experimental support. This review focuses on hydrogel-based strategies for melanoma treatment, highlighting: (1) recent advances in hydrogel design and functionality; (2) their integration with therapeutic approaches such as immunotherapy, chemotherapy, and photothermal therapy; and (3) their potential in postoperative wound management. In addition, we discuss the role of material selection in hydrogel performance and explore how the combination of distinct therapeutic approaches within hydrogel systems can synergistically improve treatment outcomes. Finally, we address the current challenges facing clinical translation, including safety, efficacy, and regulatory hurdles, while outlining potential pathways to overcome these barriers. This review aims to support future research and clinical innovation by providing a structured, up-to-date overview of hydrogel applications in melanoma therapy.

Indexed as

HydrogelsMelanomaSkin NeoplasmsAnimalsAntineoplastic AgentsDrug Delivery SystemsHumansImmunotherapyAntineoplastic AgentsHydrogelsdrug delivery systemhydrogelmelanomasynergistic therapy

Identifiers

PMID41445540
PMCPMC12723262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.